Social/economic costs and quality of life in patients with haemophilia in Europe

被引：0
作者：
Marianna Cavazza
Yllka Kodra
Patrizio Armeni
Marta De Santis
Julio López-Bastida
Renata Linertová
Juan Oliva-Moreno
Pedro Serrano-Aguilar
Manuel Posada-de-la-Paz
Domenica Taruscio
Arrigo Schieppati
Georgi Iskrov
László Gulácsi
Johann Matthias Graf von der Schulenburg
Panos Kanavos
Karine Chevreul
Ulf Persson
Giovanni Fattore
机构：
[1] Bocconi University,Centre for Research on Health and Social Care Management (CERGAS)
[2] National Centre for Rare Diseases,Department of Health Economics
[3] Istituto Superiore di Sanità (ISS),Centre for Health Economics Research Hannover (CHERH)
[4] University of Castilla-La Mancha,Department of Social Policy and LSE Health
[5] Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC),Department of Social Medicine and Public Health, Faculty of Public Health
[6] Fundación Canaria de Investigación Sanitaria (FUNCANIS),undefined
[7] University of Castilla-La Mancha,undefined
[8] Evaluation and Planning Service at Canary Islands Health Service,undefined
[9] Institute of Rare Diseases Research,undefined
[10] ISCIII,undefined
[11] SpainRDR & CIBERER,undefined
[12] “Aldo and Cele Daccò” Clinical Research Center for Rare Diseases,undefined
[13] Mario Negri Institute for Pharmacological Research,undefined
[14] Institute of Rare Diseases,undefined
[15] Corvinus University of Budapest,undefined
[16] Leibniz Universität Hannover,undefined
[17] London School of Economics and Political Science,undefined
[18] URC Eco Ile de France,undefined
[19] AP-HP,undefined
[20] The Swedish Institute for Health Economics,undefined
[21] Medical University of Plovdiv,undefined
[22] Université Paris Diderot,undefined
[23] INSERM,undefined
[24] ECEVE,undefined
来源：
The European Journal of Health Economics | 2016年 / 17卷
关键词：
Rare diseases; Haemophilia; Health related quality of life; Societal costs; Social burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 65
页数：12
相关论文
共 137 条
  • [1] Rosendal FR(1990)The increasing prevalence of haemophilia Thromb. Haemostasis 63 145-494
  • [2] Briet E(2005)Demographics of haemophilia in developing countries Semin. Thromb. Hemostasis 31 489-32
  • [3] Evatt BL(2010)A study of variations in the reported haemophilia A prevalence around the world Haemophilia 16 20-740
  • [4] Stonebraker JS(2014)Burden and management of factor XIII deficiency Haemophilia 20 733-108
  • [5] Bolton-Maggs PHB(2008)Avoiding the impact of muscolo-skeletal pain on quality of life in children with haemophilia Orthop. Nurse 27 103-577
  • [6] Soucie MJ(2003)Intracranial haemorrhage among a population of haemophilic patients in Brazil Haemophilia 9 573-S488
  • [7] DeJager T(2010)Burden of disease resulting from hemophilia in the U.S. Am. J. Prev. Med. 38 S482-32
  • [8] Pericleous L(1992)Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B J. Intern. Med. 232 25-701
  • [9] KoKot-Kierapa M(1995)Modern treatment of haemophilia Bull. World Health Organ. 73 691-544
  • [10] Sherry DD(2007)Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia N. Engl. J. Med. 357 535-534
12345678910